They are a biotechnology company focused on the development and commercialization of targeted therapies for the treatment of cancer.
Last Closing Price
February 1, 2018
Barclays, J.P. Morgan
To view the prospectus for Seattle Genetics, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253